Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Parkinson's disease and light: The bright and the Dark sides.

Maggio R, Vaglini F, Rossi M, Fasciani I, Pietrantoni I, Marampon F, Corsini GU, Scarselli M, Millan MJ.

Brain Res Bull. 2019 Aug;150:290-296. doi: 10.1016/j.brainresbull.2019.06.013. Epub 2019 Jun 19. Review.

PMID:
31226407
2.

Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences.

Aringhieri S, Carli M, Kolachalam S, Verdesca V, Cini E, Rossi M, McCormick PJ, Corsini GU, Maggio R, Scarselli M.

Pharmacol Ther. 2018 Dec;192:20-41. doi: 10.1016/j.pharmthera.2018.06.012. Epub 2018 Jun 25. Review.

PMID:
29953902
3.

Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism.

Aringhieri S, Kolachalam S, Gerace C, Carli M, Verdesca V, Brunacci MG, Rossi C, Ippolito C, Solini A, Corsini GU, Scarselli M.

Eur Neuropsychopharmacol. 2017 Apr;27(4):383-398. doi: 10.1016/j.euroneuro.2017.02.005. Epub 2017 Mar 7.

PMID:
28283227
4.

Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not.

Romeo S, Vitale F, Viaggi C, di Marco S, Aloisi G, Fasciani I, Pardini C, Pietrantoni I, Di Paolo M, Riccitelli S, Maccarone R, Mattei C, Capannolo M, Rossi M, Capozzo A, Corsini GU, Scarnati E, Lozzi L, Vaglini F, Maggio R.

Brain Res. 2017 May 1;1662:87-101. doi: 10.1016/j.brainres.2017.02.026. Epub 2017 Mar 2.

PMID:
28263713
5.

Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients.

Rossi C, Genovesi D, Marzullo P, Giorgetti A, Filidei E, Corsini GU, Bonuccelli U, Ceravolo R.

Clin Neuropharmacol. 2017 Jan/Feb;40(1):34-36. doi: 10.1097/WNF.0000000000000198.

PMID:
27941527
6.

Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: methods, dynamics and biological function.

Scarselli M, Annibale P, McCormick PJ, Kolachalam S, Aringhieri S, Radenovic A, Corsini GU, Maggio R.

FEBS J. 2016 Apr;283(7):1197-217. doi: 10.1111/febs.13577. Epub 2015 Nov 28. Review.

7.

Serotonin abnormalities in Engrailed-2 knockout mice: New insight relevant for a model of Autism Spectrum Disorder.

Viaggi C, Gerace C, Pardini C, Corsini GU, Vaglini F.

Neurochem Int. 2015 Aug;87:34-42. doi: 10.1016/j.neuint.2015.05.004. Epub 2015 May 19.

PMID:
26002543
8.

Serum uric acid levels and different phases of illness in bipolar I patients treated with lithium.

Muti M, Del Grande C, Musetti L, Marazziti D, Turri M, Cirronis M, Pergentini I, Corsi M, Dell'Osso L, Corsini GU.

Psychiatry Res. 2015 Feb 28;225(3):604-8. doi: 10.1016/j.psychres.2014.11.038. Epub 2014 Dec 17.

PMID:
25547850
9.

Eyes as gateways for environmental light to the substantia nigra: relevance in Parkinson's disease.

Romeo S, Di Camillo D, Splendiani A, Capannolo M, Rocchi C, Aloisi G, Fasciani I, Corsini GU, Scarnati E, Lozzi L, Maggio R.

ScientificWorldJournal. 2014 Jan 22;2014:317879. doi: 10.1155/2014/317879. eCollection 2014.

10.

Acetaldehyde and parkinsonism: role of CYP450 2E1.

Vaglini F, Viaggi C, Piro V, Pardini C, Gerace C, Scarselli M, Corsini GU.

Front Behav Neurosci. 2013 Jun 21;7:71. doi: 10.3389/fnbeh.2013.00071. eCollection 2013.

11.

Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology.

Romeo S, Viaggi C, Di Camillo D, Willis AW, Lozzi L, Rocchi C, Capannolo M, Aloisi G, Vaglini F, Maccarone R, Caleo M, Missale C, Racette BA, Corsini GU, Maggio R.

Sci Rep. 2013;3:1395. doi: 10.1038/srep01395.

12.

[Long-term treatment of bipolar disorder: how should we use lithium salts?].

Del Grande C, Muti M, Musetti L, Pergentini I, Corsi M, Turri M, Soldani I, Corsini GU, Dell'Osso L.

Riv Psichiatr. 2012 Nov-Dec;47(6):515-26. doi: 10.1708/1178.13058. Italian.

PMID:
23160112
13.

Behavioral, neurochemical, and electrophysiological changes in an early spontaneous mouse model of nigrostriatal degeneration.

Sgadò P, Viaggi C, Pinna A, Marrone C, Vaglini F, Pontis S, Mercuri NB, Morelli M, Corsini GU.

Neurotox Res. 2011 Aug;20(2):170-81. doi: 10.1007/s12640-010-9232-9. Epub 2010 Nov 23.

PMID:
21104462
14.

MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.

Viaggi C, Vaglini F, Pardini C, Caramelli A, Corsini GU.

Neuropharmacology. 2009 Jun;56(8):1075-81. doi: 10.1016/j.neuropharm.2009.03.003. Epub 2009 Mar 17.

PMID:
19298832
15.

Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice.

Tripathi PP, Sgadò P, Scali M, Viaggi C, Casarosa S, Simon HH, Vaglini F, Corsini GU, Bozzi Y.

Neuroscience. 2009 Mar 17;159(2):842-9. doi: 10.1016/j.neuroscience.2009.01.007. Epub 2009 Jan 10.

PMID:
19186208
16.

Ethanol intake and ethanol-induced locomotion and locomotor sensitization in Cyp2e1 knockout mice.

Correa M, Viaggi C, Escrig MA, Pascual M, Guerri C, Vaglini F, Aragon CM, Corsini GU.

Pharmacogenet Genomics. 2009 Mar;19(3):217-25. doi: 10.1097/FPC.0b013e328324e726.

PMID:
19177030
17.

Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures.

Vaglini F, Pardini C, Viaggi C, Caramelli A, Corsini GU.

Neuropharmacology. 2008 Oct;55(5):737-42. doi: 10.1016/j.neuropharm.2008.06.041. Epub 2008 Jun 27.

PMID:
18634808
18.

Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease.

Sgadò P, Viaggi C, Fantacci C, Corsini GU.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S103-6. doi: 10.1016/j.parkreldis.2008.04.011. Epub 2008 Jun 27.

PMID:
18585948
19.

Preface. Experimental models in Parkinson's disease.

Giorgi F, Corsini GU.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S79-80. doi: 10.1016/j.parkreldis.2008.04.032. Epub 2008 Jun 27. No abstract available.

PMID:
18585947
20.

Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation.

Maggio R, Novi F, Rossi M, Corsini GU, Millan MJ.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S139-44. doi: 10.1016/j.parkreldis.2008.04.018. Epub 2008 Jun 27.

PMID:
18585083
21.

Role of CYP2E1 in the mouse model of MPTP toxicity.

Pardini C, Vaglini F, Viaggi C, Caramelli A, Corsini GU.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S119-23. doi: 10.1016/j.parkreldis.2008.04.014. Epub 2008 Jun 25. Review.

PMID:
18583171
22.

CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity.

Viaggi C, Vaglini F, Pardini C, Sgadò P, Caramelli A, Corsini GU.

J Neural Transm Suppl. 2007;(72):159-63.

PMID:
17982890
24.

Assessing neuroprotection in Parkinson's disease: from the animal models to molecular neuroimaging in vivo.

Ceravolo R, Sgadò P, Frosini D, Corsini GU.

J Neural Transm Suppl. 2006;(71):133-41. Review.

PMID:
17447424
25.

TSH-Dependent expression of the LDL receptor-associated protein (RAP) in thyroid epithelial cells.

Botta R, Lisi S, Pinchera A, Segnani C, Cianferotti L, Altea MA, Menconi F, Mattii L, Corsini GU, Marcocci C, Dolfi A, Bernardini N, Marinò M.

Thyroid. 2006 Nov;16(11):1097-104.

PMID:
17123336
26.

The thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)-ethane appears to be an uncompetitive inverse agonist for the thyrotropin receptor.

Rossi M, Dimida A, Dell'anno MT, Trincavelli ML, Agretti P, Giorgi F, Corsini GU, Pinchera A, Vitti P, Tonacchera M, Maggio R.

J Pharmacol Exp Ther. 2007 Jan;320(1):465-74. Epub 2006 Oct 24.

PMID:
17062616
27.

Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity.

Viaggi C, Pardini C, Vaglini F, Corsini GU.

J Neural Transm Suppl. 2006;(70):173-6.

PMID:
17017526
28.

The impact of G-protein-coupled receptor hetero-oligomerization on function and pharmacology.

Maggio R, Novi F, Scarselli M, Corsini GU.

FEBS J. 2005 Jun;272(12):2939-46. Review.

29.

Paired activation of two components within muscarinic M3 receptor dimers is required for recruitment of beta-arrestin-1 to the plasma membrane.

Novi F, Stanasila L, Giorgi F, Corsini GU, Cotecchia S, Maggio R.

J Biol Chem. 2005 May 20;280(20):19768-76. Epub 2005 Mar 15.

30.

Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.

Vaglini F, Pardini C, Viaggi C, Bartoli C, Dinucci D, Corsini GU.

J Neurochem. 2004 Oct;91(2):285-98.

31.

The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK1/2 phosphorylation.

Novi F, Scarselli M, Corsini GU, Maggio R.

J Biol Chem. 2004 Feb 27;279(9):7476-86. Epub 2003 Dec 2.

32.

Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole.

Maggio R, Scarselli M, Novi F, Millan MJ, Corsini GU.

J Neurochem. 2003 Nov;87(3):631-41.

33.

Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf.

Scarselli M, Novi F, Corsini GU, Maggio R.

Brain Res. 2003 Oct 17;987(2):244-7.

PMID:
14499970
34.

Dose-dependent induction of apoptosis by R-apomorphine in CHO-K1 cell line in culture.

Pardini C, Vaglini F, Galimberti S, Corsini GU.

Neuropharmacology. 2003 Aug;45(2):182-9.

PMID:
12842124
35.

Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells.

Maggio R, Armogida M, Scarselli M, Salvadori F, Longoni B, Pardini C, Chiarenza A, Chiacchio S, Vaglini F, Bernardini R, Colzi A, Corsini GU.

Neurotox Res. 2000 Apr;1(4):285-97.

PMID:
12835096
36.

Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice.

Vaglini F, Pardini C, Bonuccelli U, Maggio R, Corsini GU.

Brain Res. 2003 May 30;973(2):298-302.

PMID:
12738074
37.

An unusual form of the association binding kinetics of N-[3H]methylscopolamine to the split muscarinic M2trunk/M2tail receptor.

Novi F, Scarselli M, Corsini GU, Maggio R.

J Pharmacol Exp Ther. 2003 May;305(2):786-95. Epub 2003 Jan 24.

PMID:
12606698
38.

Cytochrome p450 and parkinsonism: protective role of CYP2E1.

Vaglini F, Pardini C, Viaggi C, Corsini GU.

Funct Neurol. 2001;16(4 Suppl):107-12. Review. No abstract available.

PMID:
11996504
39.

Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1.

Chiarenza A, Scarselli M, Novi F, Lempereur L, Bernardini R, Corsini GU, Maggio R.

Eur J Pharmacol. 2001 Dec 14;433(1):47-54.

PMID:
11755133
40.

Apomorphine. A novel effect for an old compound.

Scarselli M, Armogida M, Pardini C, Chiacchio S, Corsini GU.

Adv Neurol. 2001;86:367-72. Review. No abstract available.

PMID:
11553998
41.

D2/D3 dopamine receptor heterodimers exhibit unique functional properties.

Scarselli M, Novi F, Schallmach E, Lin R, Baragli A, Colzi A, Griffon N, Corsini GU, Sokoloff P, Levenson R, Vogel Z, Maggio R.

J Biol Chem. 2001 Aug 10;276(32):30308-14. Epub 2001 May 23.

42.

Reconstitution of functional dopamine D(2s) receptor by co-expression of amino- and carboxyl-terminal receptor fragments.

Scarselli M, Armogida M, Chiacchio S, DeMontis MG, Colzi A, Corsini GU, Maggio R.

Eur J Pharmacol. 2000 Jun 2;397(2-3):291-6.

PMID:
10844126
43.

Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment.

Fornai F, Giorgi FS, Bassi L, Ferrucci M, Alessandrì MG, Corsini GU.

Brain Res. 2000 Apr 7;861(1):126-34.

PMID:
10751572
44.

Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat.

Fornai F, Saviozzi M, Piaggi S, Gesi M, Corsini GU, Malvaldi G, Casini AF.

Neuroscience. 1999;94(3):937-48.

PMID:
10579586
45.

G protein-linked receptors: pharmacological evidence for the formation of heterodimers.

Maggio R, Barbier P, Colelli A, Salvadori F, Demontis G, Corsini GU.

J Pharmacol Exp Ther. 1999 Oct;291(1):251-7.

PMID:
10490911
46.

Is lithium able to reverse neurological damage induced by vinca alkaloids? (Short communication).

Petrini M, Vaglini F, Cervetti G, Cavalletti M, Sartucci F, Murri L, Corsini GU.

J Neural Transm (Vienna). 1999;106(5-6):569-75.

PMID:
10443559
47.

Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells.

Scarselli M, Barbier P, Salvadori F, Armogida M, Collecchi P, Pardini C, Vaglini F, Maggio R, Corsini GU.

J Neural Transm Suppl. 1999;55:47-55.

PMID:
10335492
48.
49.

Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors.

Maggio R, Riva M, Vaglini F, Fornai F, Molteni R, Armogida M, Racagni G, Corsini GU.

J Neurochem. 1998 Dec;71(6):2439-46.

50.

Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor.

Barbier P, Colelli A, Bolognesi ML, Minarini A, Tumiatti V, Corsini GU, Melchiorre C, Maggio R.

Eur J Pharmacol. 1998 Aug 21;355(2-3):267-74.

PMID:
9760041

Supplemental Content

Loading ...
Support Center